Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 20 September 1985:
Vol. 229. no. 4719, pp. 1230 - 1235
DOI: 10.1126/science.3898361
Prev | Table of Contents | Next

Articles

Science, Vol 229, Issue 4719, 1230-1235
Copyright © 1985 by American Association for the Advancement of Science

articles

Biotechnology in pharmaceuticals: the Japanese challenge

MD Dibner

The products of biotechnology are being developed for new diagnostics and therapeutics, and it is predicted that they will have great impact on the pharmaceutical industry. In the United States, pharmaceutical companies are incorporating biotechnology into their research and development programs, often with the contractual assistance of small biotechnology firms. Their strongest competition is arising in Japan, where there are now concerted government and industry efforts to expand biotechnology capabilities and to optimize commercialization. Strategies used by the United States and Japan to incorporate biotechnology into their pharmaceutical industries are examined and compared.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Technological Diversification of Japanese Industry.
F. KODAMA (1986)
Science 233, 291-296
   Abstract »    PDF »
Biotechnology in Europe.
M. D. DIBNER (1986)
Science 232, 1367-1372
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)